[{"from": "human", "value": "Provide a description of this molecule. [C][C][C][C][C][C][C][C][C][C][C][C@H1][Branch2][Branch2][O][C][C][=Branch1][C][=O][N][C@@H1][C@H1][Branch2][Branch1][P][C@@H1][Branch2][Branch1][Ring2][C@H1][Branch2][Ring2][=C][O][C@H1][Ring1][=Branch1][O][C][C@@H1][Branch1][=Branch1][C][=Branch1][C][=O][O][N][C][=Branch1][C][=O][C][C@@H1][Branch1][N][C][C][C][C][C][C][C][C][C][C][C][O][C][C][C][C][C][C][C][C][C][C][C][O][O][P][=Branch1][C][=O][Branch1][C][O][O][O][C][=Branch1][C][=O][C][C@@H1][Branch1][N][C][C][C][C][C][C][C][C][C][C][C][O][C][C][C][C][C][C][C][C][C][C][O][C][C][C][C][C][C][C][C][C][C]"}, {"from": "gpt", "value": "The molecule is a toll-like receptor 4 (TLR4) agonist, with potential immunoadjuvant activity. Upon administration, GSK1795091 binds to and activates TLR4, thereby stimulating dendritic cells (DCs), monocytes and macrophages. This activation results in the production of pro-inflammatory cytokines, including interferon gamma (IFN-g), tumor necrosis factor-alpha (TNF-a) and the interleukins (IL), IL-1 beta, -6 and -12. This may induce a T helper cell-1 (Th1) immune response and, upon co-administration of a vaccine containing tumor-associated antigens (TAAs), activates a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing those TAAs. TLR4, a member of the TLR family, plays a key role in the activation of innate immunity."}]